Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996

Cancer

Volumn 89, Issue 1, 2000, Pages 192-201

  Hölzer, Simon ^a   Reiners, Christian ^b   Mann, Klaus ^c   Bamberg, Michael ^d   Rothmund, Matthias ^e   Dudeck, Joachim ^a   Stewart, Andrew K ^f   Hundahl, Scott A ^g  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f AMERICAN COLLEGE OF SURGEONS   (United States)

^g Queen's Cancer Institute   (United States)

Author keywords

Adjuvant treatment; Complications; Diagnostics; Follicular carcinoma; Hormonal therapy; Iodine 131; Papillary carcinoma; Surgery; Thyroid carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GRADING; DIAGNOSTIC ACCURACY; DYSPHAGIA; FEMALE; GERMANY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NECK PAIN; NECK TUMOR; PRIORITY JOURNAL; STRIDOR; SYMPTOM; THYROID CARCINOMA;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGED; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; GERMANY; HUMANS; IODINE RADIOISOTOPES; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0343953100     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000701)89:1<192::AID-CNCR26>3.0.CO;2-7     Document Type: Article

References (37)

1. Krebsregister Saarland. Morbidität und mortalität an bösartigen Neubildungen, Jahresbericht 1992. Edition 180. Saarbruecken, Germany: State of Saarland, 1995.
2. Fraker DL, Skarulis M, Livolsi V. Thyroid tumors. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. 5th edition. Philadelphia: Lippincott-Raven, 1997:1629-48.
3. Sanders LE, Cady B. Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Arch Surg 1998;133:419-25.
4. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990;19:545-76.
5. Mazzaferri EL. Treating differentiated thyroid carcinoma: where do we draw the line? [editorial; comment]. Mayo Clin Proc. 1991;66:105-11.
6. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-8.
7. Goretzki PE, Simon D, Frilling A, Witte J, Reiners C, Grussendorf M, et al. Surgical reintervention for differentiated thyroid cancer. Br J Surg 1993;80:1009-12.
8. Simon D, Goretzki PE, Witte J, Roher HD. Incidence of regional recurrence guiding radicality in differentiated thyroid carcinoma. World J Surg 1996;20:860-6.
9. Goretzki PE, Witte J, Ohman C, Stallmann C, Röher HD. On the significance of lymph-node metastases of differentiated thyroid carcinoma on tumor recurrence and patient survival (a quantitative approach by meta-analysis and multivariate analysis of retrospective studies). Exp Clin Endocrinol Diabetes 1993;101:118-23.
10. Samaan NA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA, et al. The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992;75:714-20.
11. Scheumann GF, Seeliger H, Musholt TI, Gimm O, Wegener G, Dralle H, et al. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma. Eur J Surg 1996;162: 677-84.
12. Shaha AR, Shah JP, Loree TR. Low-risk differentiated thyroid cancer: the need for selective treatment. Ann Surg Oncol 1997;4:328-33.
13. Shaha AR, Loree TR, Shah JP. Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 1995;118:1131-6.
14. Solomon BL, Wartofsky L, Burman KD. Current trends in the management of well differentiated papillary thyroid carcinoma. J. Clin Endocrinol Metab 1996;81:333-9.
15. Jossart GH, Clark OH. Well-differentiated thyroid cancer. Curr Probl Surg 1994;31:933-1012.
16. Gagel RF, Goepfert H, Callender DL. Changing concepts in the pathogenesis and management of thyroid carcinoma. CA Cancer J Clin 1996;46:261-83.
17. Hölzer S, Dudeck J. Patient Care Evaluation Studies: applying this concept of quality management in oncology. Stud Health Technol Inform 1997;43(Pt B):834-8.
18. Hölzer S, Dudeck J. Redesigning and adapting a concept of quality management in oncology. In: Masys DR, editor. Journal of the American Informatics Association. Philadelphia: Hanley & Belfus, Inc., 1997:950.
19. Hölzer S, Dudeck I. Patient Care Evaluation Studien als Werkzeug der Qualitätssicherung in der Onkologie- Ist eine Übertragung auf Deutsche Verhältnisse möglich? Biomed J 1998;51:8-11.
20. Jessup JM, Menck HR, Winchester DP, Hundahl SA, Murphy GP. The National Cancer Data Base report on patterns of hospital reporting. Cancer 1996;78:1829-37.
21. Clive RE, Ocwieja KM, Kamell L, Hoyler SS, Seiffert JE, Young JL, et al. A national quality improvement effort: cancer registry data. J Surg Oncol 1995;58:155-61.
22. Mettlin CJ, Murphy GP, Ho R, Menck HR. The National Cancer Data Base report on longitudinal observations on prostate cancer. Cancer 1996;77:2162-6.
23. Winchester DJ, Menck HR, Winchester DP. The National Cancer Data Base report on the results of a large nonrandomized comparison of breast preservation and modified radical mastectomy. Cancer 1997;80:162-7.
24. Menck HR, Cunningham MP, Jessup JM, Eyre HJ, Winchester DP, Scott CC, et al. The growth and maturation of the National Cancer Data Base. Cancer 1997;80:2296-304.
25. Fremgen AM, Jessup JM, Menck HR. Hospital use of NCDB data to assess quality of cancer patient care. J Registry Manage 1995;22:69-71.
26. World Health Organization. ICD-O-2 International classification of diseases for oncology. 2nd edition. Geneva, Switzerland: World Health Organization, 1990.
27. TNM classification of malignant tumors. 5th Edition. In: Sobin LH, Wittekind CH, editors. Geneva, Switzerland: International Union Against Cancer, 1997:47-50.
28. SPSS Inc. SPSS for Windows, Advanced Statistics. Release 8.0. Chicago: SPSS Inc., 1997.
29. Balan KK, Raouf AH, Critchley M. Outcome of 249 patients attending a nuclear medicine department with well differentiated thyroid cancer: a 23 year review [see comments]. Br J Radiol 1994;67:283-91.
30. Farahati I, Reiners C, Stuschke M, Muller SP, Stuben G, Sauerwein W, et al. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4). Cancer 1996;77:172-80.
31. Hannequin P, Liehn JC, Delisle MJ. Multifactorial analysis of survival in thyroid cancer. Pitfalls of applying the results of published studies to another population. Cancer 1986;58: 1749-55.
32. Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-7.
33. Mazzaferri EL, Jhiang SM. Differentiated thyroid cancer long-term impact of initial therapy. Trans Am Clin Climatol Assoc 1994;106:151-68.
34. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988;104:947-53.
35. DeGroot LJ. Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer [editorial; comment]. Am J Med 1994;97:499-500.
36. DeGroot LJ, Kaplan EL, Straus FH, Shukla MS. Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 1994;18:123-30.
37. Meng G. Deutschland ein Jodmangelgebiet. Deutsches Ärzteblatt 1994;23:1366-70.